JAK inhibitors: a promising direction for treating Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is a chronic auto inflammatory disease that causes incapacitating changes both the musculoskeletal system and the internal organs [1].

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-06-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.17352/IJPSDR.000013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sirukumab: a promising therapy for rheumatoid arthritis

  2017cited by this paper
• Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival.

  2014cited by this paper

• Rheumatoid arthritis: Treatment evolution over the years

  2020cites this paper
• ABP 501 for the treatment of rheumatoid arthritis

  2018cites this paper